Hong-Sheng Zhang

Dr. Hong-Sheng Zhang

Faculty of Environment and Life, Beijing University of Technology, Beijing 100124, China

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2019 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
Hong-Sheng ZhangHong-Sheng Zhang
Hong-Sheng Zhang
ZZZhong‐Guo Zhang
Zhong‐Guo Zhang
GDGuang‐Yuan Du
Guang‐Yuan Du
HSHong‐Liang Sun
Hong‐Liang Sun
HLHui‐Yun Liu
Hui‐Yun Liu
YHYing‐Hui Huang
Ying‐Hui Huang
Abnormal metabolism of tumour cells is closely related to the occurrence and development of breast cancer, during which the expression of NF‐E2‐related factor 2 (Nrf2) is of great significance. Metastatic breast cancer is one of the most common causes of cancer death worldwide; however, the molecular mechanism underlying breast cancer metastasis remains unknown. In this study, we found that the overexpression of Nrf2 promoted proliferation and migration of breast cancers cells. Inhibition of Nrf2 and overexpression of Kelch‐like ECH‐associated protein 1 (Keap1) reduced the expression of glucose‐6‐phosphate dehydrogenase (G6PD) and transketolase of pentose phosphate pathway, and overexpression of Nrf2 and knockdown of Keap1 had opposite effects. Our results further showed that the overexpression of Nrf2 promoted the expression of G6PD and Hypoxia‐inducing factor 1α (HIF‐1α) in MCF‐7 and MDA‐MB‐231 cells. Overexpression of Nrf2 up‐regulated the expression of Notch1 via G6PD/HIF‐1α pathway. Notch signalling pathway affected the proliferation of breast cancer by affecting its downstream gene HES‐1, and regulated the migration of breast cancer cells by affecting the expression of EMT pathway. The results suggest that Nrf2 is a potential molecular target for the treatment of breast cancer and targeting Notch1 signalling pathway may provide a promising strategy for the treatment of Nrf2‐driven breast cancer metastasis.

8 March 2022 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
MLMin-Yao Liu
Min-Yao Liu
HLHong-Ming Li
Hong-Ming Li
XWXin-Yu Wang
Xin-Yu Wang
RXRan Xia
Ran Xia
XLXiang Li
Xiang Li
Hong-Sheng ZhangHong-Sheng Zhang
Hong-Sheng Zhang

19 May 2023 in The FEBS Journal
Verified
Journal Article
Closed access
XLXiang Li
Xiang Li
Hong-Sheng ZhangHong-Sheng Zhang
Hong-Sheng Zhang

1 June 2019 in Experimental Cell Research
Verified
Journal Article
Closed access
ZZZhong-Guo Zhang
Zhong-Guo Zhang
Hong-Sheng ZhangHong-Sheng Zhang
Hong-Sheng Zhang
HSHong-Liang Sun
Hong-Liang Sun
HLHui-Yun Liu
Hui-Yun Liu
MLMin-Yao Liu
Min-Yao Liu
ZZZhen Zhou
Zhen Zhou

1 February 2018 in The International Journal of Biochemistry & Cell Biology
Verified
Journal Article
Closed access
Hong-Sheng ZhangHong-Sheng Zhang
Hong-Sheng Zhang
GDGuang-Yuan Du
Guang-Yuan Du
ZZZhong-Guo Zhang
Zhong-Guo Zhang
ZZZhen Zhou
Zhen Zhou
HSHong-Liang Sun
Hong-Liang Sun
YHYing-Hui Huang
Ying-Hui Huang

1 August 2009 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
Hong-Sheng ZhangHong-Sheng Zhang
Hong-Sheng Zhang
HLHong-Yan Li
Hong-Yan Li
YZYue Zhou
Yue Zhou
MWMeng-Ran Wu
Meng-Ran Wu
HZHong-Sen Zhou
Hong-Sen Zhou